Webinars and podcasts
Stay up to date with the latest developments at Isogenica. Our webinars and podcasts feature expert discussions on emerging VHH applications, research insights, and industry trends.
Webinars
On-demand webinar: “Small modalities, deep impact”: VHH antibodies as complementary approaches for challenging therapeutic targets
This webinar was held in collaboration with our CRO partner AXXAM
Protein & Antibody Engineering Summit VHH as Building Blocks for Immune and Tumour
This webinar “Protein & Antibody Engineering Summit VHH as Building Blocks for Immune and Tumour” was presented at PEGS Europe 2021.
Nature: Using synthetic VHH to optimize T-cell mediated immunotherapies
This webinar summarises the clinical and research landscape for CAR-T and T-cell engaging antibody therapies and show how single domain VHH antibodies can be applied to optimise the next generation of these important new therapeutic modalities.
What Makes Cancer so Hard?
Why is Cancer so Hard? Claudia Fernandes tells us her thoughts…
In our second edition of Why is Cancer so Hard? we chat to Claudia Fernandes, Alliances Manager, about her take on why cancer is so difficult to treat and, eventually, cure:
Why is Cancer so Hard? Marion Cubbitt tells us her thoughts…
Researchers have been trying to fight cancer for over 100 years, yet there’s still no cure. What makes treating cancer so challenging? We asked our Director of Discovery for her views…